{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:37:49Z","timestamp":1788824269536,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00277-024-05752-6","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T04:02:20Z","timestamp":1713326540000},"page":"3043-3052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey"],"prefix":"10.1007","volume":"103","author":[{"given":"Andrea","family":"Duminuco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isacco","family":"Ferrarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Santuccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chiarenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Figuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Anastasia","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Alberto","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Mogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Moioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"issue":"5","key":"5752_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.hoc.2020.05.002","volume":"34","author":"A Navarro","year":"2020","unstructured":"Navarro A, Be\u00e0 S, Jares P, Campo E (2020) Molecular pathogenesis of Mantle Cell Lymphoma. Hematol Oncol Clin North Am 34(5):795","journal-title":"Hematol Oncol Clin North Am"},{"key":"5752_CR2","doi-asserted-by":"crossref","unstructured":"Silkenstedt E, Linton K, Dreyling M Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches. Br J Haematol [Internet]. 2021 Oct 1 [cited 2022 Jun 24];195(2):162\u201373. https:\/\/pubmed.ncbi.nlm.nih.gov\/33783838\/","DOI":"10.1111\/bjh.17419"},{"key":"5752_CR3","doi-asserted-by":"crossref","unstructured":"Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A et al Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network. J Clin Oncol [Internet]. 2014 May 1 [cited 2022 Jun 24];32(13):1338\u201346. https:\/\/pubmed.ncbi.nlm.nih.gov\/24687837\/","DOI":"10.1200\/JCO.2013.52.2466"},{"key":"5752_CR4","doi-asserted-by":"crossref","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC et al A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood [Internet]. 2008 Jan 15 [cited 2022 Jun 24];111(2):558\u201365. https:\/\/pubmed.ncbi.nlm.nih.gov\/17962512\/","DOI":"10.1182\/blood-2007-06-095331"},{"key":"5752_CR5","doi-asserted-by":"crossref","unstructured":"Dreyling M, Campo E, Hermine O, Jerkeman M, le Gouill S, Rule S et al (2017) Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol [Internet]. [cited 2022 Jun 24];28(suppl_4):iv62\u201371. https:\/\/pubmed.ncbi.nlm.nih.gov\/28881919\/","DOI":"10.1093\/annonc\/mdx223"},{"key":"5752_CR6","doi-asserted-by":"crossref","unstructured":"Burger JA, Gribben JG (2014) The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies. Semin Cancer Biol [Internet]. [cited 2022 Nov 14];24:71\u201381. https:\/\/pubmed.ncbi.nlm.nih.gov\/24018164\/","DOI":"10.1016\/j.semcancer.2013.08.011"},{"key":"5752_CR7","doi-asserted-by":"crossref","unstructured":"Chiron D, Bellanger C, Papin A, Tessoulin B, Dousset C, Maiga S et al (2016) Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma. Blood [Internet]. Dec 15 [cited 2022 Nov 14];128(24):2808\u201318. https:\/\/pubmed.ncbi.nlm.nih.gov\/27697772\/","DOI":"10.1182\/blood-2016-06-720490"},{"key":"5752_CR8","doi-asserted-by":"crossref","unstructured":"Saba NS, Liu D, Herman SEM, Underbayev C, Tian X, Behrend D et al Pathogenic role of B-cell receptor signaling and canonical NF-\u03baB activation in mantle cell lymphoma. Blood [Internet]. 2016 Jul 7 [cited 2022 Nov 14];128(1):82. Available from: \/pmc\/articles\/PMC4937360\/","DOI":"10.1182\/blood-2015-11-681460"},{"key":"5752_CR9","doi-asserted-by":"crossref","unstructured":"Duminuco A, Nardo A, Orofino A, Giunta G, Conticello C, Del Fabro V et al Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions. Cancer [Internet]. 2024 Jan 1 [cited 2024 Jan 13];130(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/37658645\/","DOI":"10.1002\/cncr.35005"},{"key":"5752_CR10","doi-asserted-by":"publisher","unstructured":"Duminuco A, Romano A, Leotta D, La Spina E, Cambria D, Bulla A et al (2023) Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab\/cilgavimab. Front Oncol [Internet]. Mar 29 [cited 2023 Mar 29];13:1357. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fonc.2023.1157610\/full","DOI":"10.3389\/fonc.2023.1157610\/full"},{"key":"5752_CR11","doi-asserted-by":"crossref","unstructured":"Saleh K, Cheminant M, Chiron D, Burroni B, Ribrag V, Sarkozy C (2072) Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma. Cancers 2022, Vol 14, Page 3229 [Internet]. 2022 Jun 30 [cited 2022 Dec 11];14(13):3229. https:\/\/www.mdpi.com\/-6694\/14\/13\/3229\/htm","DOI":"10.3390\/cancers14133229"},{"key":"5752_CR12","doi-asserted-by":"crossref","unstructured":"Papin A, le Gouill S, Chiron D Rationale for targeting tumor cells in their microenvironment for mantle cell lymphoma treatment. Leuk Lymphoma [Internet]. 2018 May 4 [cited 2022 Nov 14];59(5):1064\u201372. https:\/\/pubmed.ncbi.nlm.nih.gov\/28758825\/","DOI":"10.1080\/10428194.2017.1357177"},{"key":"5752_CR13","doi-asserted-by":"crossref","unstructured":"Romano A, Parrinello NL, Vetro C, Forte S, Chiarenza A, Figuera A et al Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy. Br J Haematol [Internet]. 2015 Mar 1 [cited 2024 Jan 13];168(5):689\u2013700. https:\/\/pubmed.ncbi.nlm.nih.gov\/25376846\/","DOI":"10.1111\/bjh.13198"},{"key":"5752_CR14","doi-asserted-by":"crossref","unstructured":"Giallongo S, Duminuco A, Dulcamare I, Zuppelli T, La Spina E, Scandura G et al Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers. Biomolecules [Internet]. 2023 Dec 1 [cited 2024 Jan 13];13(12). https:\/\/pubmed.ncbi.nlm.nih.gov\/38136573\/","DOI":"10.3390\/biom13121701"},{"key":"5752_CR15","unstructured":"Song M, Graubard BI, Rabkin CS, Engels EA Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Scientific Reports 2021 11:1 [Internet]. 2021 Jan 11 [cited 2022 Dec 11];11(1):1\u20139. https:\/\/www.nature.com\/articles\/s41598-020-79431-7"},{"key":"5752_CR16","doi-asserted-by":"crossref","unstructured":"Chan JCY, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A et al The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg [Internet]. 2017 Mar 1 [cited 2022 Dec 11];265(3):539\u201346. https:\/\/journals.lww.com\/annalsofsurgery\/Fulltext\/2017\/03000\/The_Lymphocyte_to_Monocyte_Ratio_is_a_Superior.17.aspx","DOI":"10.1097\/SLA.0000000000001743"},{"key":"5752_CR17","doi-asserted-by":"crossref","unstructured":"Pan YC, Jia ZF, Cao DH, Wu YH, Jiang J, Wen SM et al Preoperative lymphocyte-to-monocyte ratio (LMR) could independently predict overall survival of resectable gastric cancer patients. Medicine (United States) [Internet]. 2018 Dec 1 [cited 2022 Dec 11];97(52). https:\/\/journals.lww.com\/md-journal\/Fulltext\/2018\/12280\/Preoperative_lymphocyte_to_monocyte_ratio__LMR_.76.aspx","DOI":"10.1097\/MD.0000000000013896"},{"key":"5752_CR18","doi-asserted-by":"crossref","unstructured":"Djordjevic D, Rondovic G, Surbatovic M, Stanojevic I, Udovicic I, Andjelic T et al (2018) Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm [Internet]. [cited 2022 Dec 11];2018. https:\/\/pubmed.ncbi.nlm.nih.gov\/30116146\/","DOI":"10.1155\/2018\/3758068"},{"key":"5752_CR19","doi-asserted-by":"crossref","unstructured":"BG S, Gosavi S, Rao AA, Shastry S, Raj SC, Sharma A et al Neutrophil-to-Lymphocyte, Lymphocyte-to-Monocyte, and Platelet-to-Lymphocyte Ratios: Prognostic Significance in COVID-19. Cureus [Internet]. 2021 Jan 11 [cited 2022 Dec 11];13(1). https:\/\/www.cureus.com\/articles\/48272-neutrophil-to-lymphocyte-lymphocyte-to-monocyte-and-platelet-to-lymphocyte-ratios-prognostic-significance-in-covid-19","DOI":"10.7759\/cureus.12622"},{"key":"5752_CR20","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fneur.2019.01310","volume":"10","author":"W He","year":"2019","unstructured":"He W, Ruan Y, Yuan C, Cheng Q, Cheng H, Zeng Y et al (2019) High neutrophil-to-platelet ratio is Associated with Hemorrhagic Transformation in patients with Acute ischemic stroke. Front Neurol 10:1310","journal-title":"Front Neurol"},{"key":"5752_CR21","doi-asserted-by":"crossref","unstructured":"Zahorec R (2021) Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy [Internet]. [cited 2022 Dec 11];122(7):474\u201388. https:\/\/pubmed.ncbi.nlm.nih.gov\/34161115\/","DOI":"10.4149\/BLL_2021_078"},{"key":"5752_CR22","doi-asserted-by":"crossref","unstructured":"Di Raimondo C, Caposiena Caro RD, Spallone D, Silvaggio D, Lombardo P, del Duca E et al Baseline neutrophil\/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinoma. Int J Dermatol [Internet]. 2022 Feb 1 [cited 2022 Dec 11];61(2):175\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/34212366\/","DOI":"10.1111\/ijd.15755"},{"key":"5752_CR23","doi-asserted-by":"crossref","unstructured":"Mano Y, Shirabe K, Yamashita YI, Harimoto N, Tsujita E, Takeishi K et al (2013) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg [Internet]. Aug [cited 2022 Dec 11];258(2):301\u20135. https:\/\/pubmed.ncbi.nlm.nih.gov\/23774313\/","DOI":"10.1097\/SLA.0b013e318297ad6b"},{"key":"5752_CR24","doi-asserted-by":"crossref","unstructured":"Santoni M, de Giorgi U, Iacovelli R, Conti A, Burattini L, Rossi L et al Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma. Br J Cancer [Internet]. 2013 Oct 10 [cited 2022 Dec 11];109(7):1755. Available from: \/pmc\/articles\/PMC3790174\/","DOI":"10.1038\/bjc.2013.522"},{"key":"5752_CR25","doi-asserted-by":"crossref","unstructured":"Romano A, Parrinello NL, Consoli ML, Marchionni L, Forte S, Conticello C et al Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents. Ann Hematol [Internet]. 2015 Nov 22 [cited 2022 Dec 11];94(11):1875. Available from: \/pmc\/articles\/PMC4695982\/","DOI":"10.1007\/s00277-015-2462-4"},{"key":"5752_CR26","doi-asserted-by":"crossref","unstructured":"Porrata LF, Ristow K, Habermann T, Inwards DJ, Micallef IN, Markovic SN Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil\/lymphocyte ratio. Am J Hematol [Internet]. 2010 Nov [cited 2022 Dec 11];85(11):896\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/20842639\/","DOI":"10.1002\/ajh.21849"},{"key":"5752_CR27","doi-asserted-by":"crossref","unstructured":"Lucijanic M, Cicic D, Stoos-Veic T, Pejsa V, Lucijanic J, Dzankic AF et al Elevated Neutrophil-to-Lymphocyte-ratio and Platelet-to-Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself? Anticancer Res [Internet]. 2018 May 1 [cited 2022 Dec 11];38(5):3157\u201363. https:\/\/pubmed.ncbi.nlm.nih.gov\/29715157\/","DOI":"10.21873\/anticanres.12579"},{"key":"5752_CR28","doi-asserted-by":"crossref","unstructured":"Romano A, Parrinello NL, Vetro C, Chiarenza A, Cerchione C, Ippolito M et al Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy. Ann Hematol [Internet]. 2018 Jun 1 [cited 2022 Jun 24];97(6):1009\u201318. https:\/\/pubmed.ncbi.nlm.nih.gov\/29442162\/","DOI":"10.1007\/s00277-018-3276-y"},{"key":"5752_CR29","doi-asserted-by":"publisher","unstructured":"Rodrigues JM, Nikkarinen A, Hollander P, Weibull CE, R\u00e4ty R, Kolstad A et al (2021) Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. Br J Haematol [Internet]. May 1 [cited 2022 Dec 11];193(3):520\u201331. https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/bjh.17366","DOI":"10.1111\/bjh.17366"},{"key":"5752_CR30","doi-asserted-by":"crossref","unstructured":"Kamoshida G, Matsuda A, Sekine W, Mizuno H, Oku T, Itoh S et al (2012) Monocyte differentiation induced by co-culture with tumor cells involves RGD-dependent cell adhesion to extracellular matrix. Cancer Lett [Internet]. Feb 28 [cited 2022 Dec 18];315(2):145\u201352. https:\/\/pubmed.ncbi.nlm.nih.gov\/22104730\/","DOI":"10.1016\/j.canlet.2011.09.029"},{"key":"5752_CR31","doi-asserted-by":"crossref","unstructured":"Papin A, Tessoulin B, Bellanger C, Moreau A, le Bris Y, Maisonneuve H et al (2019) CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages. Leukemia [Internet]. Oct 1 [cited 2022 Dec 18];33(10):2442\u201353. https:\/\/pubmed.ncbi.nlm.nih.gov\/30940906\/","DOI":"10.1038\/s41375-019-0463-3"},{"key":"5752_CR32","doi-asserted-by":"crossref","unstructured":"Stoiber D, Assinger A (2020) Platelet-Leukocyte Interplay in Cancer Development and Progression. Cells [Internet]. Apr 1 [cited 2022 Dec 11];9(4). Available from: \/pmc\/articles\/PMC7226828\/","DOI":"10.3390\/cells9040855"},{"key":"5752_CR33","doi-asserted-by":"crossref","unstructured":"Gabrilovich DI (2017) Myeloid-Derived Suppressor Cells. Cancer Immunol Res [Internet]. Jan 1 [cited 2022 Jun 24];5(1):3\u20138. https:\/\/pubmed.ncbi.nlm.nih.gov\/28052991\/","DOI":"10.1158\/2326-6066.CIR-16-0297"},{"key":"5752_CR34","doi-asserted-by":"crossref","unstructured":"Honigberg LA, Smith AM, Sirisawad M, Verner E, Loury D, Chang B, S A [Internet] The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U. 2010 Jul 20 [cited 2022 Jun 24];107(29):13075\u201380. https:\/\/pubmed.ncbi.nlm.nih.gov\/20615965\/","DOI":"10.1073\/pnas.1004594107"},{"key":"5752_CR35","doi-asserted-by":"crossref","unstructured":"Gao F, Hu J, Zhang J, Xu Y Prognostic Value of Peripheral Blood Lymphocyte\/monocyte Ratio in Lymphoma. J Cancer [Internet]. 2021 [cited 2024 Mar 3];12(12):3407. Available from: \/pmc\/articles\/PMC8120176\/","DOI":"10.7150\/jca.50552"},{"key":"5752_CR36","doi-asserted-by":"crossref","unstructured":"Stefaniuk P, Szymczyk A, Podhorecka M (2020) The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies \u2013 A Narrative Review. Cancer Manag Res [Internet]. [cited 2024 Mar 3];12:2961. Available from: \/pmc\/articles\/PMC7196794\/","DOI":"10.2147\/CMAR.S245928"},{"key":"5752_CR37","doi-asserted-by":"crossref","unstructured":"Le K, Sun J, Khawaja H, Shibata M, Maggirwar SB, Smith MR et al (2021) Mantle cell lymphoma polarizes tumor-associated macrophages into M2-like macrophages, which in turn promote tumorigenesis. Blood Adv [Internet]. Jul 27 [cited 2024 Mar 3];5(14):2863\u201378. https:\/\/pubmed.ncbi.nlm.nih.gov\/34297045\/","DOI":"10.1182\/bloodadvances.2020003871"},{"key":"5752_CR38","doi-asserted-by":"crossref","unstructured":"Palumbo GA, Parrinello NL, Giallongo C, D\u2019amico E, Zangh\u00ec A, Puglisi F et al Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies. Int J Mol Sci [Internet]. 2019 Nov 1 [cited 2024 Mar 3];20(21). Available from: \/pmc\/articles\/PMC6862591\/","DOI":"10.3390\/ijms20215459"},{"key":"5752_CR39","doi-asserted-by":"crossref","unstructured":"Pham LV, Vang MT, Tamayo AT, Lu G, Challagundla P, Jorgensen JL et al Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease. Leuk Lymphoma [Internet]. 2015 Jan 1 [cited 2024 Mar 3];56(1):186\u201393. https:\/\/pubmed.ncbi.nlm.nih.gov\/24611650\/","DOI":"10.3109\/10428194.2014.901511"},{"key":"5752_CR40","doi-asserted-by":"crossref","unstructured":"Araujo-Ayala F, Doba\u00f1o-L\u00f3pez C, Valero JG, Nadeu F, Gava F, Faria C et al A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses. Leukemia [Internet]. 2023 Jun 1 [cited 2024 Mar 3];37(6):1311\u201323. https:\/\/pubmed.ncbi.nlm.nih.gov\/37031299\/","DOI":"10.1038\/s41375-023-01885-1"},{"key":"5752_CR41","doi-asserted-by":"crossref","unstructured":"Koh YW, Shin SJ, Park C, Yoon DH, Suh C, Huh J Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages. Hematol Oncol [Internet]. 2014 Dec 1 [cited 2024 Mar 3];32(4):178\u201386. https:\/\/pubmed.ncbi.nlm.nih.gov\/24910369\/","DOI":"10.1002\/hon.2106"},{"key":"5752_CR42","doi-asserted-by":"crossref","unstructured":"von Aprile K, Conconi A, de Campos CP, Franceschetti S, Bertoni F, Margiotta Casaluci G et al (2013) Prognostic impact of monocyte count at presentation in mantle cell lymphoma. Br J Haematol [Internet]. Aug [cited 2024 Mar 3];162(4):465\u201373. https:\/\/pubmed.ncbi.nlm.nih.gov\/23808798\/","DOI":"10.1111\/bjh.12409"},{"key":"5752_CR43","doi-asserted-by":"crossref","unstructured":"Locati M, Curtale G, Mantovani A, Diversity Mechanisms, and Significance of Macrophage Plasticity. Annu Rev Pathol [Internet]. 2020 Jan 24 [cited 2024 Mar 3];15:123\u201347. https:\/\/pubmed.ncbi.nlm.nih.gov\/31530089\/","DOI":"10.1146\/annurev-pathmechdis-012418-012718"},{"key":"5752_CR44","doi-asserted-by":"crossref","unstructured":"Ugel S, Canegrave S, De Sanctis F, Bronte V Monocytes in the Tumor Microenvironment. Annu Rev Pathol [Internet]. 2021 Jan 24 [cited 2024 Mar 3];16:93\u2013122. https:\/\/pubmed.ncbi.nlm.nih.gov\/33497262\/","DOI":"10.1146\/annurev-pathmechdis-012418-013058"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05752-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05752-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:06:36Z","timestamp":1722060396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05752-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["5752"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05752-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of conflicts of interest"}},{"value":"All patients or legal guardians provided written informed consent. The study was approved by Ethic Committee Catania 1 (54\/2022\/PO, 31\/03\/2022).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}}]}}